Activated checkpoint kinase 2 provides a survival signal for tumor cells

Jagadish C. Ghosh, Takehiko Dohi, Christopher M. Raskett, Timothy F. Kowalik, Dario C. Altieri

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Tumor cells often become resistant to DNA damage-based therapy; however, the underlying mechanisms are not yet understood. Here, we show that tumor cells exposed to DNA damage counteract cell death by releasing the antiapoptotic protein, survivin, from mitochondria. This is independent of p53, and requires activated checkpoint kinase 2 (Chk2), a putative tumor suppressor. Molecular or genetic targeting of Chk2 prevents the release of survivin from mitochondria, enhances DNA damage-induced tumor cell apoptosis, and inhibits the growth of resistant in vivo tumors. Therefore, activated Chk2 circumvents its own tumor-suppressive functions by promoting tumor cell survival. Inhibiting Chk2 in combination with DNA-damaging agents may provide a rational approach for treating resistant tumors.

Original languageEnglish (US)
Pages (from-to)11576-11579
Number of pages4
JournalCancer Research
Volume66
Issue number24
DOIs
StatePublished - Dec 15 2006

Fingerprint

Checkpoint Kinase 2
Neoplasms
DNA Damage
Mitochondria
Molecular Biology
Cell Survival
Cell Death
Apoptosis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Ghosh, J. C., Dohi, T., Raskett, C. M., Kowalik, T. F., & Altieri, D. C. (2006). Activated checkpoint kinase 2 provides a survival signal for tumor cells. Cancer Research, 66(24), 11576-11579. https://doi.org/10.1158/0008-5472.CAN-06-3095
Ghosh, Jagadish C. ; Dohi, Takehiko ; Raskett, Christopher M. ; Kowalik, Timothy F. ; Altieri, Dario C. / Activated checkpoint kinase 2 provides a survival signal for tumor cells. In: Cancer Research. 2006 ; Vol. 66, No. 24. pp. 11576-11579.
@article{1903d9a24c2749b49db8ca0194d5c438,
title = "Activated checkpoint kinase 2 provides a survival signal for tumor cells",
abstract = "Tumor cells often become resistant to DNA damage-based therapy; however, the underlying mechanisms are not yet understood. Here, we show that tumor cells exposed to DNA damage counteract cell death by releasing the antiapoptotic protein, survivin, from mitochondria. This is independent of p53, and requires activated checkpoint kinase 2 (Chk2), a putative tumor suppressor. Molecular or genetic targeting of Chk2 prevents the release of survivin from mitochondria, enhances DNA damage-induced tumor cell apoptosis, and inhibits the growth of resistant in vivo tumors. Therefore, activated Chk2 circumvents its own tumor-suppressive functions by promoting tumor cell survival. Inhibiting Chk2 in combination with DNA-damaging agents may provide a rational approach for treating resistant tumors.",
author = "Ghosh, {Jagadish C.} and Takehiko Dohi and Raskett, {Christopher M.} and Kowalik, {Timothy F.} and Altieri, {Dario C.}",
year = "2006",
month = "12",
day = "15",
doi = "10.1158/0008-5472.CAN-06-3095",
language = "English (US)",
volume = "66",
pages = "11576--11579",
journal = "Cancer Research",
issn = "0008-5472",
number = "24",

}

Ghosh, JC, Dohi, T, Raskett, CM, Kowalik, TF & Altieri, DC 2006, 'Activated checkpoint kinase 2 provides a survival signal for tumor cells', Cancer Research, vol. 66, no. 24, pp. 11576-11579. https://doi.org/10.1158/0008-5472.CAN-06-3095

Activated checkpoint kinase 2 provides a survival signal for tumor cells. / Ghosh, Jagadish C.; Dohi, Takehiko; Raskett, Christopher M.; Kowalik, Timothy F.; Altieri, Dario C.

In: Cancer Research, Vol. 66, No. 24, 15.12.2006, p. 11576-11579.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Activated checkpoint kinase 2 provides a survival signal for tumor cells

AU - Ghosh, Jagadish C.

AU - Dohi, Takehiko

AU - Raskett, Christopher M.

AU - Kowalik, Timothy F.

AU - Altieri, Dario C.

PY - 2006/12/15

Y1 - 2006/12/15

N2 - Tumor cells often become resistant to DNA damage-based therapy; however, the underlying mechanisms are not yet understood. Here, we show that tumor cells exposed to DNA damage counteract cell death by releasing the antiapoptotic protein, survivin, from mitochondria. This is independent of p53, and requires activated checkpoint kinase 2 (Chk2), a putative tumor suppressor. Molecular or genetic targeting of Chk2 prevents the release of survivin from mitochondria, enhances DNA damage-induced tumor cell apoptosis, and inhibits the growth of resistant in vivo tumors. Therefore, activated Chk2 circumvents its own tumor-suppressive functions by promoting tumor cell survival. Inhibiting Chk2 in combination with DNA-damaging agents may provide a rational approach for treating resistant tumors.

AB - Tumor cells often become resistant to DNA damage-based therapy; however, the underlying mechanisms are not yet understood. Here, we show that tumor cells exposed to DNA damage counteract cell death by releasing the antiapoptotic protein, survivin, from mitochondria. This is independent of p53, and requires activated checkpoint kinase 2 (Chk2), a putative tumor suppressor. Molecular or genetic targeting of Chk2 prevents the release of survivin from mitochondria, enhances DNA damage-induced tumor cell apoptosis, and inhibits the growth of resistant in vivo tumors. Therefore, activated Chk2 circumvents its own tumor-suppressive functions by promoting tumor cell survival. Inhibiting Chk2 in combination with DNA-damaging agents may provide a rational approach for treating resistant tumors.

UR - http://www.scopus.com/inward/record.url?scp=33846188519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846188519&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-3095

DO - 10.1158/0008-5472.CAN-06-3095

M3 - Article

C2 - 17178848

AN - SCOPUS:33846188519

VL - 66

SP - 11576

EP - 11579

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 24

ER -